Activity Info
This case based panel discussion reviews the recent guidelines and the latest clinical information related to the treatment of RCC with immunotherapeutic agents.
Release Date: November 30, 2022
Expiration Date: November 30, 2023
Time to Complete: 1 Hour
Sumanta K. Pal, MD, FASCO
Professor, Department of Medical Oncology and Therapeutics Research
Co-Director, Kidney Cancer Program
City of Hope
Duarte, CA
Tian Zhang, MD, MHS
Associate Professor
Division of Hematology and Oncology
Deptartment of Internal Medicine
UT Southwestern Medical Center
Harold C Simmons Comprehensive Cancer Center
Dallas, TX
